Editas Medicine (EDIT) Capital Expenditures (2015 - 2025)
Editas Medicine (EDIT) reported Capital Expenditures of -$114000.0 for Q3 2025, down 103.9% year-over-year from $2.9 million in Q3 2024, and down 200.0% quarter-over-quarter from $114000.0 in Q1 2025.
Editas Medicine (EDIT) Capital Expenditures (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Capital Expenditures data on file, last reported at -$114000.0 in Q3 2025.
- Capital Expenditures for Q3 2025 came in at -$114000.0, down 103.9% year-over-year; the trailing twelve-month figure through Sep 2025 was -$8.2 million (down 243.75% YoY), and the FY2024 annual result was $65000.0, down 92.31% from the prior year.
- Capital Expenditures fell to -$114000.0 in Q3 2025 per EDIT's latest filing, from $114000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.5 million in Q2 2024 and troughed at -$8.2 million in Q4 2024.
- A 5-year average of $320944.4 and a median of $388000.0 in 2021 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 2576.19% in 2022, then plunged 511.38% in 2023.
- A 5-year view of Capital Expenditures shows it stood at $152000.0 in 2021, then soared by 310.53% to $624000.0 in 2022, then sank by 511.38% to -$2.6 million in 2023, then slumped by 220.26% to -$8.2 million in 2024, then jumped by 98.61% to -$114000.0 in 2025.
- Business Quant data shows EDIT's Capital Expenditures at -$114000.0 in Q3 2025, $114000.0 in Q1 2025, and -$8.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -114,000.00 |
| Sep 30, 2025 | -114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | -8.22 Mn |
| Dec 31, 2024 | -8.22 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 3.49 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.87 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Dec 31, 2023 | -2.57 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | -1.63 Mn |
| Jun 30, 2023 | -1.63 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.84 Mn |